Currently viewing: Report of the Audit Committee / Next: Directors' report
In line with the requirements of King IVTM* and the Companies Act, the Life Healthcare Group Holdings Limited’s audit committee (the Committee) is pleased to present its report for the year ended 30 September 2021.
The primary role of the Committee is to assist the Board in discharging its Group governance oversight responsibilities. These responsibilities relate to the safeguarding of assets, monitoring the adequacy and effectiveness of the Group’s systems and control environment, including that the Group has appropriate financial reporting procedures and that those procedures are operating as intended, and oversight over the integrated report preparation and fairly presented annual financial statements, in compliance with all applicable legal and regulatory requirements and accounting standards. The Chairman of the Committee reports to the Board on the Committee’s deliberations and decisions.
Members of the Committee are formally nominated by the Board for re-election by shareholders at the annual general meeting (AGM). The individual members satisfy the requirements to serve as members of an audit committee, as provided in section 94 of the Companies Act and they have the requisite level of knowledge and experience to fulfil their duties.
The Chairman of the Board, Group Chief Executive, Group Chief Financial Officer, Group Chief Internal Audit Executive, Group Risk Manager and senior management in the financial function attend meetings at the invitation of the Committee, together with the external auditor. In line with best practice, the internal and external auditors have unrestricted access to the Committee, where they can raise any matter that requires the Committee’s attention, and they also have the opportunity to meet with the Committee without members of management being present. The Chairman of the Committee and Ms AM Mothupi are also members of the risk, compliance, and IT governance committee, which ensures the flow of information between the two committees.
The Committee composition in the year, attendance as well as qualifications are set out below:
| Name | Qualifications | Date appointed | Attendance |
| Peter Golesworthy Chairman) | BA (Hons), Accounting Studies, CA | 10 June 2010 | 5/5 |
| Caroline Henry | CA(SA) | 1 September 2021 | 0/0 (first meeting was on 1 Oct 2021) |
| Cindy Hess | CA(SA) | 1 September 2021 | 0/0 (first meeting was on 1 Oct 2021) |
| Audrey Mothupi | BA (Honours) Political Science | 3 July 2017 | 5/5 |
| Garth Solomon* | CA(SA) | 10 June 2010 | 5/5 |
| Royden Vice | CA(SA) | 1 February 2014 | 5/5 |
Four (4) scheduled meetings and one (1) special meeting were held during the year
* Garth Solomon resigned from the Committee on 31 August 2021.
* Copyright and trademarks are owned by the Institute of Directors South Africa NPC and all of its rights are reserved.
The Committee welcomed Ms Caroline Henry and Ms Cindy Hess as new members to the Committee and looks forward to their contribution. The Committee recognised, with thanks, the important role played by Mr Solomon during his tenure on the Committee.
Members were assessed by the nominations and governance committee, on behalf of the Board, in terms of the requirements of King IV and the Companies Act. The current members of the Committee continue to meet the independence requirements.
The current Committee members will be recommended to the shareholders at the next AGM for appointment for the financial year ending 30 September 2022.
The Committee has adopted comprehensive and formal terms of reference that can be viewed on the Group’s website at www.lifehealthcare.co.za.
The Committee has discharged its responsibilities as contained in the terms of reference, including ensuring that financial information issued to stakeholders is prepared in alignment with legislation and best practice. More specifically, the main functions performed by the Committee during the year under review were as follows:
The Committee received regular reports on the key finance initiatives. At the end of 2020, the finance team in South Africa was restructured, creating a centralised Group finance function under the leadership of the newly appointed General Manager: Finance, who reports directly into the Group Chief Financial Officer. Some of the finance functions that existed solely within South Africa were relocated to Group in order to standardise processes and Group expertise. The restructure also has the benefit of allowing for better employee development and succession planning.
Both SAP and OneStream have been successfully implemented across the Group. The new systems will allow for better reporting and improved future planning.
The management teams continued to learn, adapt, and change to accommodate the evolving COVID-19 environment. The finance team operates using the hybrid working model, namely working from home as well as coming into the office on a regular basis. This allowed for more effective communication within the team as well as better discussion and reporting in respect of financial matters. Regular feedback was provided on remote working and engagement with teams working virtually to ensure the integrity of financial reports and the Committee was kept appraised of the actions taken to ensure that the finance functions across the Group operated effectively.
The Committee considered the appropriateness and adequacy of resources and experience of the finance function and confirmed its satisfaction.
Mr PP van der Westhuizen is the Group Chief Financial Officer (Group CFO). He is a qualified chartered accountant and has practised as one for over 25 years. He has been employed in the role of Group CFO of the Group since 2013.
The Committee reviewed the qualifications and experience of Mr PP van der Westhuizen and was satisfied that his skill, expertise and experience were appropriate to meet the requirements of the position.
The Committee considered the COVID-19 global pandemic (the pandemic) and associated impact on the Group’s operations and the preparation of the 2021 annual financial statements. The Committee is satisfied that the events related to the pandemic have been disclosed accordingly in the annual financial statements. The impact of the pandemic necessitated ongoing review of the following key matters:
The Committee considered management’s documentation relating to the going concern assumption used in the financial statements. In recommending to the Board that the going concern assumption was an appropriate basis for preparing the annual financial statements, the Committee, inter alia, considered the budget for the 2022 financial year, liquidity forecasts, including the assumptions and sensitivities and available committed and uncommitted debt facilities.
The Committee ensured that the internal audit function is independent and has the necessary resources to enable it to fulfil its mandate. The Group Chief Internal Audit Executive reports functionally to the Committee Chairman and administratively to the Group Chief Financial Officer. An outsourced internal audit function operates across the Group, with the Group Chief Internal Audit Executive responsible for co-ordinating the planning, implementing and reporting thereon.
Towards the end of 2020, the outsourced internal audit function transitioned from Ernst & Young (EY) in South Africa to PriceWaterhouseCoopers (PwC). With effect from 1 October 2021, the outsourced function transitioned from BDO in the International operations to PwC, resulting in PwC providing the outsourced internal audit services across the Group. In addition to a smooth transition with the outsourced audit function, the Chief Internal Audit Executive expanded his team with the appointment of two persons. This has assisted in ensuring that tasks are carried out in accordance with the audit plan and the closing out of audit findings once remediated by management.
The internal audit function continues to provide a professional independent service, with due regard to the tenets of its charter, and has the full support of the Group Chief Executive Officer (Group CEO) and the Group CFO. Given the various services provided by PwC, care has been taken to ensure that the necessary policies are in place to ensure the independence of PwC as internal auditor.
The Committee:
The pandemic continued to impact internal audit’s ability to perform its audits, which necessitated the re-prioritisation of a number of assignments during the year.
Following approval by shareholders at the AGM in January 2021, Deloitte served as the Group’s registered external auditor for the 2021 financial year. Mr Bongisipho Nyembe was appointed as the designated partner for 2021, but it is with sadness that we report that he passed away in August 2021 from a COVID-19-related illness. Bongisipho was an invaluable member of the Deloitte team and had demonstrated his integrity and commitment to Life Healthcare in the difficult first year of Deloitte’s audit in 2020. Mr J Welch was approved as the designated partner to succeed Bongisipho and the JSE was accordingly notified of the change.
2021 was Deloitte’s second year as the external auditor and this was an easier process for both it and management after the impact of COVID-19 and the cyber-attack in the previous year.
For the year under review the Committee:
The Committee resolved to recommend to the shareholders that Deloitte be appointed as the Group’s registered external auditor for the 2022 financial year and Mr J Welch as the designated partner.
The JSE Listings requirement for the attestation by the Group CEO and Group CFO relating to controls and fairly presented financial statements became effective in 2021. The Committee received regular updates on the processes that were adopted to review the control environment and to provide the Group CEO and Group CFO with the necessary assurance to enable them to provide the attestation which is set out in the Statement of Group Chief Executive and Group Chief Financial Officer in the financial statements.
The Group CEO and Group CFO reviewed the controls over financial reporting and presented the findings to the Committee. This evaluation included:
Based on this evaluation, management identified certain deficiencies relating to the IT General Control environment, which included a number of high, medium and low risk areas, with a significant improvement noted over the prior year. The evaluation also identified gaps in certain financial controls, but these were largely mitigated by compensating controls and did not lead to any material concerns with the financial reporting process.
As part of the Group’s ongoing journey towards strengthening the internal controls related to financial reporting, a remediation plan has been developed by management to address control deficiencies, which is planned to be completed in stages, especially as it relates to control improvements associated with control disciplines and the implementation of new computer systems.
This rigorous process has enabled the Group CEO and Group CFO to conclude and sign-off on the effectiveness of the internal controls over financial reporting, in accordance with the JSE Listings Requirements.
The audit committee in turn has discussed the documented basis for management’s conclusion, including discussions with the internal and external auditors as well as with management. The Committee believes that the Group’s internal controls can be relied upon as a reasonable basis for the preparation of the annual financial statements.
The table below sets out the key focus areas for 2021 that were set out in last year’s report and the Company’s progress in relation to those areas.
| Focus area | Met/Work in Progress/Not Met | |
| Continued oversight of the South African system projects and the SAP project within the International operations | Met. The Committee received regular updates in relation to various projects | |
| Oversight of the newly appointed internal auditors and the delivery of the internal audit plan | Met. There has been a smooth transition from EY in South Africa to PWC in the current year and PwC was involved in the 2022 planning following its appointment for the International business from 1 October 2021 | |
| Continued evaluation, with the support of the risk, compliance and IT governance committee, of the key risks, related controls and mitigations in respect of the IT infrastructure and project implementation, as it related to internal controls | Work in Progress. There has been a marked improvement in addressing the key risks in the IT infrastructure and key projects | |
| Overseeing the accounting for the disposal of Scanmed and the subsequent disclosures to the market following the sale | Met. The Committee received detailed reports on the disposal of Scanmed and reviewed the disclosures | |
| Continuous focus on the Group’s reporting processes and financial controls and integration of the International operations. | Met. The Committee received regular reports on the financial controls and on the International operations’ integration |
For the new financial year the Committee will continue to review management’s efforts to enhance the risk and control environment. Key areas of focus will include:
The Committee confirms that for the 2021 financial year, it has discharged its responsibilities in accordance with its terms of reference and in compliance with the requirements of the Companies Act, the JSE Listings Requirements and all other relevant legislation.
I would like to record my appreciation to colleagues on the Committee, as well the management team and the internal and external auditors, for all the hard work and dedication through the year.
For and on behalf of the Committee.
PJ Golesworthy
Chairman: audit committee
Johannesburg
15 November 2021